Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF and Rituximab

This study is currently recruiting participants.

Study NCT00208975 Information provided by Emory University

First Received: September 13, 2005 Last Updated: June 24, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	May 2015
Estimated Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)